
Last week, the Metaphore team hosted its second annual Science Day to focus on the scientific questions, patient needs, and cross-functional work that will shape what comes next. The program brought together perspectives on the future of antibody discovery and the path toward the clinic. Just as important, it created time for teams across biology, computation, discovery, and development to connect ideas and ask questions. A highlight was hearing from Andy Jablonski, founder of the Short Bowel Syndrome Foundation, Inc., and a person living with short bowel syndrome (SBS). His perspective on living with SBS and his work with the community connected the day’s scientific discussions with the patient experience. We also heard from Andrew Kruse on GPCR signaling and from Tony Manning and Enoch Huang on the questions still ahead in antibody discovery. Thank you to our speakers and everyone at Metaphore who contributed to the day. For more on Metaphore’s approach to designing antibodies that activate, tune, and engage biology, see our new website and animation: metaphorebio.com/science
















